Posted: Thursday, April 4, 2024
Kerollos N. Wanis, MD, PhD, of The University of Texas MD Anderson Cancer Center, discusses his findings on the risk of future ipsilateral and contralateral breast cancer events and survival without bilateral mastectomy in patients with BRCA1 or BRCA2 mutation.